Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug;39(8):957-9.
doi: 10.1038/ng2063. Epub 2007 Jul 15.

Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes

Sibel Kantarci  1 , Lihadh Al-Gazali, R Sean Hill, Dian Donnai, Graeme C M Black, Eric Bieth, Nicolas Chassaing, Didier Lacombe, Koen Devriendt, Ahmad Teebi, Maria Loscertales, Caroline Robson, Tianming Liu, David T MacLaughlin, Kristin M Noonan, Meaghan K Russell, Christopher A Walsh, Patricia K Donahoe, Barbara R Pober
Affiliations

Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes

Sibel Kantarci et al. Nat Genet. 2007 Aug.

Abstract

Donnai-Barrow syndrome is associated with agenesis of the corpus callosum, congenital diaphragmatic hernia, facial dysmorphology, ocular anomalies, sensorineural hearing loss and developmental delay. By studying multiplex families, we mapped this disorder to chromosome 2q23.3-31.1 and identified LRP2 mutations in six families with Donnai-Barrow syndrome and one family with facio-oculo-acoustico-renal syndrome. LRP2 encodes megalin, a multiligand uptake receptor that regulates levels of diverse circulating compounds. This work implicates a pathway with potential pharmacological therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of LRP2 mutations and corresponding megalin domains. LRP2 sequencing uncovered missense, nonsense, frameshift or splice junction mutations in individuals with DBS/FOAR from seven kindreds. Mutations are indicated adjacent to the megalin extracellular domains that they affect; mutation ‘hotspots’ or genotype-phenotype correlations are not apparent. Mat, maternally inherited mutation; pat, paternally inherited mutation (Supplementary Table 3).
Figure 2
Figure 2
MRI abnormalities in individuals with DBS/FOAR. (a) Sagittal T1-weighted magnetic resonance image of subject 1, kindred 5, showing ACC with associated absence of cingulate gyrus. (b) Sagittal T1-weighted magnetic resonance image of subject IV-6, kindred 1, showing arrested development of corpus callosum with truncation of posterior body, absence of splenium and rostrum of corpus callosum, partially empty sella (s) and small-appearing pons (P). (c,d) Axial FSE T2-weighted magnetic resonance image of subject IV-6, kindred 1, showing subependymal nodular heterotopia (c) and enlarged globes with small colobomas at the optic nerve heads (d). (e) Axial computed tomography of temporal bones of subject IV-6, kindred 1, showing globular malformation of the left horizontal semicircular canal and vestibule. Abnormalities are indicated by arrows in a–e. (f–i) Brain cortical surface reconstruction from spoiled gradient-echo (SPGR) structural magnetic resonance image. f shows a frontal right view and g shows a top view for a 4-year-old control. Central sulcus, precentral gyrus and postcentral gyrus are labeled by a red curve, a white arrow and a yellow arrow, respectively. h shows a frontal right view and i shows a top view for subject IV-6, kindred 1, with DBS/FOAR. Note abnormally developed frontal lobe and unrecognizable abnormally placed central sulcus.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Donnai D, et al. Am. J. Med. Genet. 1993;47:679–682. - PubMed
    1. Chassaing N, et al. Am. J. Med. Genet. A. 2003;121:258–262. - PubMed
    1. Holmes LB, et al. J. Pediatr. 1972;81:552–555. - PubMed
    1. Devriendt K, et al. J. Med. Genet. 1998;35:70–71. - PMC - PubMed
    1. Christensen EI, et al. Nat. Rev. Mol. Cell Biol. 2002;3:256–266. - PubMed

Publication types

MeSH terms

Substances